# Complement Suppresses the Initial Type 1 Interferon Response to Ocular Herpes Simplex Virus Type 1 Infection in Mice

**Authors:** Daniel J. J. Carr, Adrian Filiberti, Grzegorz B. Gmyrek

PMC · DOI: 10.3390/pathogens13010074 · 2024-01-13

## TL;DR

The complement system suppresses the early immune response to a herpes virus in mice, leading to higher virus replication in the eye.

## Contribution

This study reveals a novel role of the complement system in suppressing the type I interferon response during early HSV-1 infection in mice.

## Key findings

- C3KO mice had less infectious virus in the cornea at 24 hours post-infection compared to wild-type mice.
- C3KO mice showed increased type I interferon gene expression at early time points after infection.
- Only CCL3 (MIP-1α) levels were significantly different between WT and C3KO mice at 12 hours post-infection.

## Abstract

The complement system (CS) contributes to the initial containment of viral and bacterial pathogens and clearance of dying cells in circulation. We previously reported mice deficient in complement component 3 (C3KO mice) were more sensitive than wild-type (WT) mice to ocular HSV-1 infection, as measured by a reduction in cumulative survival and elevated viral titers in the nervous system but not the cornea between days three and seven post infection (pi). The present study was undertaken to determine if complement deficiency impacted virus replication and associated changes in inflammation at earlier time points in the cornea. C3KO mice were found to possess significantly (p < 0.05) less infectious virus in the cornea at 24 h pi that corresponded with a decrease in HSV-1 lytic gene expression at 12 and 24 h pi compared to WT animals. Flow cytometry acquisition found no differences in the myeloid cell populations residing in the cornea including total macrophage and neutrophil populations at 24 h pi with minimal infiltrating cell populations detected at the 12 h pi time point. Analysis of cytokine and chemokine content in the cornea measured at 12 and 24 h pi revealed that only CCL3 (MIP-1α) was found to be different between WT and C3KO mice with >2-fold increased levels (p < 0.05, ANOVA and Tukey’s post hoc t-test) in the cornea of WT mice at 12 h pi. C3KO mouse resistance to HSV-1 infection at the early time points correlated with a significant increase in type I interferon (IFN) gene expression including IFN-α1 and IFN-β and downstream effector genes including tetherin and RNase L (p < 0.05, Mann–Whitney rank order test). These results suggest early activation of the CS interferes with the induction of the type I IFN response and leads to a transient increase in virus replication following corneal HSV-1 infection.

## Linked entities

- **Genes:** C3 (complement C3) [NCBI Gene 718], IFNA1 (interferon alpha 1) [NCBI Gene 3439], IFNB1 (interferon beta 1) [NCBI Gene 3456], BST2 (bone marrow stromal cell antigen 2) [NCBI Gene 684], RNASEL (ribonuclease L) [NCBI Gene 6041], CCL3 (C-C motif chemokine ligand 3) [NCBI Gene 6348]
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Cdk4 (cyclin dependent kinase 4) [NCBI Gene 12567] {aka Crk3}, IFNB1 (interferon beta 1) [NCBI Gene 3456] {aka IFB, IFF, IFN-beta, IFNB}, Cxcl1 (C-X-C motif chemokine ligand 1) [NCBI Gene 14825] {aka Fsp, Gro1, KC, Mgsa, N51, Scyb1}, Cfb (complement factor B) [NCBI Gene 14962] {aka Bf, C2, Fb, H2-Bf}, Ly6c1 (lymphocyte antigen 6 family member C1) [NCBI Gene 17067] {aka Ly-6C, Ly-6C1, Ly6c}, Cxcl2 (C-X-C motif chemokine ligand 2) [NCBI Gene 20310] {aka CINC-2a, GROb, Gro2, MIP-2, MIP-2a, Mgsa-b}, Cxcl10 (C-X-C motif chemokine ligand 10) [NCBI Gene 15945] {aka C7, CRG-2, INP10, IP-10, IP10, Ifi10}, Sting1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 72512] {aka 2610307O08Rik, ERIS, MPYS, Mita, STING, STING-beta}, Cd3e (CD3 antigen, epsilon polypeptide) [NCBI Gene 12501] {aka CD3, CD3epsilon, T3e}, Ifna1 (interferon alpha 1) [NCBI Gene 15962] {aka If1ai14, Ifa1}, Klrb1c (killer cell lectin-like receptor subfamily B member 1C) [NCBI Gene 17059] {aka CD161, Klrb1b, Ly-59, Ly55c, Ly59, NK-RP1}, Ifnb1 (interferon beta 1, fibroblast) [NCBI Gene 15977] {aka IFN-beta, IFNB, If1da1, Ifb}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, Cd4 (CD4 antigen) [NCBI Gene 12504] {aka L3T4, Ly-4}, Isg15 (ISG15 ubiquitin-like modifier) [NCBI Gene 100038882] {aka G1p2, IGI15, IP17, Irfp, UCRP}, Ifna (interferon alpha complex region) [NCBI Gene 111654] {aka Ifa, Ifa8}, Ccr2 (C-C motif chemokine receptor 2) [NCBI Gene 12772] {aka Cc-ckr-2, Ccr2a, Ccr2b, Ckr2, Ckr2a, Ckr2b}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, Rsad2 (radical S-adenosyl methionine domain containing 2) [NCBI Gene 58185] {aka 2510004L01Rik, SAND, Vig1, cig5}, Csf1r (colony stimulating factor 1 receptor) [NCBI Gene 12978] {aka CD115, CSF-1R, Csfmr, Fim-2, Fim2, Fms}, Adgre1 (adhesion G protein-coupled receptor E1) [NCBI Gene 13733] {aka DD7A5-7, EGF-TM7, Emr1, F4/80, Gpf480, Ly71}, H2 (histocompatibility-2, MHC) [NCBI Gene 111364] {aka H-2, MHC-II}, Ptprc (protein tyrosine phosphatase receptor type C) [NCBI Gene 19264] {aka B220, CD45R, Cd45, L-CA, Ly-5, Lyt-4}, Ccl3 (C-C motif chemokine ligand 3) [NCBI Gene 20302] {aka G0S19-1, LD78alpha, MIP-1alpha, MIP1-(a), MIP1-alpha, Mip1a}, Rnasel (ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent)) [NCBI Gene 24014] {aka E230029I04Rik}, Ccl4 (C-C motif chemokine ligand 4) [NCBI Gene 20303] {aka AT744.1, Act-2, MIP-1B, Mip1b, Scya4}, Ifitm1 (interferon induced transmembrane protein 1) [NCBI Gene 68713] {aka 1110036C17Rik, DSPA2a, Mil-2, Mil2}, Il1a (interleukin 1 alpha) [NCBI Gene 16175] {aka Il-1a}, Ccl2 (C-C motif chemokine ligand 2) [NCBI Gene 20296] {aka HC11, JE, MCAF, MCP-1, MCP1, SMC-CF}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Eif2ak2 (eukaryotic translation initiation factor 2-alpha kinase 2) [NCBI Gene 19106] {aka 2310047A08Rik, 4732414G15Rik, Pkr, Prkr, Tik}, CCL3 (C-C motif chemokine ligand 3) [NCBI Gene 6348] {aka G0S19-1, LD78, LD78ALPHA, MIP-1-alpha, MIP1A, SCI}, C3 (complement component 3) [NCBI Gene 12266] {aka ASP, HSE-MSF, Plp}, Cx3cr1 (C-X3-C motif chemokine receptor 1) [NCBI Gene 13051] {aka mCX3CR1}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Bst2 (bone marrow stromal cell antigen 2) [NCBI Gene 69550] {aka 2310015I10Rik, Bst-2, CD317, DAMP-1, GREG}, Ifne (interferon epsilon) [NCBI Gene 230405] {aka If1ea, Ifn-tau-1, Ifne1, Ifnt1, Infe1}, Csf3 (colony stimulating factor 3 (granulocyte)) [NCBI Gene 12985] {aka Csfg, G-CSF, MGI-IG}, Il9 (interleukin 9) [NCBI Gene 16198] {aka Il-9, P40}, Itgam (integrin alpha M) [NCBI Gene 16409] {aka CD11b/CD18, CR3, CR3A, Cd11b, F730045J24Rik, Ly-40}, Ly6g (lymphocyte antigen 6 family member G) [NCBI Gene 546644] {aka Gr-1, Gr1, Ly-6G}, Gc (vitamin D binding protein) [NCBI Gene 14473] {aka DBP, VDB}
- **Diseases:** cornea blindness (MESH:D065306), Inflammatory (MESH:D007249), HSV ocular disease (MESH:D016849), complement deficiency (MESH:D007153), PI (MESH:D000094025), ocular autoimmune diseases (MESH:D001327), Ocular Infection (MESH:D015817), injury to people or property (MESH:C000719191), cornea infection (MESH:D007239), HSV-1 Infection (MESH:D006561), corneal opacity (MESH:D003318)
- **Chemicals:** Cy5.5 (MESH:C098793), FITC (MESH:D016650), SB (MESH:D000965), nitric oxide (MESH:D009569), xylazine (MESH:D014991), Trizol (MESH:C411644), CS (-), paraformaldehyde (MESH:C003043), L-glutamine (MESH:D005973)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Human alphaherpesvirus 1 (Herpes simplex virus type 1, no rank) [taxon 10298]
- **Cell lines:** C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10820508/full.md

---
Source: https://tomesphere.com/paper/PMC10820508